Furthermore, reduced expression of HIP2 in the brain by genetic approach increased the vulnerability of dopaminergic neurons and leads to motor function deficits in mice, thus suggesting reduced HIP2 expression observed in PD patients is likely a contributing factor for disease progression. This evidence concerns the gene UBE2K and Parkinson disease.